B. Braun Issues Voluntary Recall of Lactated Ringer’s Injection

28 Apr 2026 //

FDA

Enforcement Report - Week of September 24, 2025

24 Sep 2025 //

FDA

Enforcement Report - Week of September 10, 2025

10 Sep 2025 //

FDA

Enforcement Report - Week of August 20, 2025

20 Aug 2025 //

FDA

B. Braun Issues Voluntary Nationwide Recall of Ringer’s Injection

19 Aug 2025 //

FDA

Enforcement Report - Week of April 16, 2025

16 Apr 2025 //

FDA

B. Braun Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection

08 Aug 2024 //

FDA

Enforcement Report - Week of April 10, 2024

10 Apr 2024 //

FDA

Enforcement Report - Week of May 24, 2023

24 May 2023 //

FDA

Health Canda Issues Recall of B. Braun Medical`s Heparin sodium in 5% Dextrose injection

11 May 2023 //

HEALTH CANADA

Enforcement Report - Week of March 15, 2023

15 Mar 2023 //

FDA

Enforcement Report - Week of March 1, 2023

01 Mar 2023 //

FDA

Enforcement Report - Week of December 14, 2022

14 Dec 2022 //

FDA

Enforcement Report - Week of March 23, 2022

23 Mar 2022 //

FDA

B. Braun Medical Inc. Issues Voluntary Nationwide Recall of 0.9% Sodium Chloride for Injection USP 250ML

04 Mar 2022 //

FDA

Enforcement Report - Week of May 6, 2020

06 May 2020 //

FDA

B. Braun Medical Issues Voluntary Nationwide Recall of One (1) Lot of Ceftazidime for Injection USP and Dextrose Injection USP

21 Apr 2020 //

FDA

Enforcement Report - Week of March 7, 2018

07 Mar 2018 //

FDA

Enforcement Report - Week of December 27, 2017

27 Dec 2017 //

FDA

B. Braun Medical Inc. on Health Canada Inspection List

11 Jul 2017 //